Mammographic density and breast cancer risk in breast screening assessment cases and women with a family history of breast cancer
48 - 56
EUROPEAN JOURNAL OF CANCER
MetadataShow full item record
Background Mammographic density has been shown to be a strong independent predictor of breast cancer and a causative factor in reducing the sensitivity of mammography. There remain questions as to the use of mammographic density information in the context of screening and risk management, and of the association with cancer in populations known to be at increased risk of breast cancer. Aim To assess the association of breast density with presence of cancer by measuring mammographic density visually as a percentage, and with two automated volumetric methods, Quantra™ and VolparaDensity™. Methods The TOMosynthesis with digital MammographY (TOMMY) study of digital breast tomosynthesis in the Breast Screening Programme of the National Health Service (NHS) of the United Kingdom (UK) included 6020 breast screening assessment cases (of whom 1158 had breast cancer) and 1040 screened women with a family history of breast cancer (of whom two had breast cancer). We assessed the association of each measure with breast cancer risk in these populations at enhanced risk, using logistic regression adjusted for age and total breast volume as a surrogate for body mass index (BMI). Results All density measures showed a positive association with presence of cancer and all declined with age. The strongest effect was seen with Volpara absolute density, with a significant 3% (95% CI 1–5%) increase in risk per 10 cm3 of dense tissue. The effect of Volpara volumetric density on risk was stronger for large and grade 3 tumours. Conclusions Automated absolute breast density is a predictor of breast cancer risk in populations at enhanced risk due to either positive mammographic findings or family history. In the screening context, density could be a trigger for more intensive imaging.
AuthorsDuffy, SW; Morrish, OWE; Allgood, PC; Black, R; Gillan, MGC; Willsher, P; Cooke, J; Duncan, KA; Michell, MJ; Dobson, HM
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as Creative Commons Attribution License
Showing items related by title, author, creator and subject.
Mammographic breast density refines Tyrer-Cuzick estimates of breast cancer risk in high-risk women: findings from the placebo arm of the International Breast Cancer Intervention Study I Warwick, J; Birke, H; Stone, J; Warren, RML; Pinney, E; Brentnall, AR; Duffy, SW; Howell, A; Cuzick, J (2014)
Benefits and harms of breast cancer mammography screening for women at average risk of breast cancer: A systematic review for the European Commission Initiative on Breast Cancer. Canelo-Aybar, C; Ferreira, DS; Ballesteros, M; Posso, M; Montero, N; Solà, I; Saz-Parkinson, Z; Lerda, D; Rossi, PG; Duffy, SW (Sage, 2021-02-25)OBJECTIVES: Mammography screening is generally accepted in women aged 50-69, but the balance between benefits and harms remains controversial in other age groups. This study systematically reviews these effects to inform ...
Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial Cuzick, J; Sestak, I; Cawthorn, S; Hamed, H; Holli, K; Howell, A; Forbes, JF; Investigators, IBIS-I (2015-01)